M
Medpace Holdings, Inc. (MEDP)
NMS – Real vaqt narxi. Valyuta: USD
419.75
+2.46 (0.59%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
419.75
+2.46 (0.59%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Medpace Holdings, Inc. Shimoliy Amerika, Yevropa, Osiyo, Janubiy Amerika, Afrika va Avstraliyada klinik tadqiqotlarga asoslangan dori va tibbiy qurilmalar ishlab chiqish xizmatlarini taqdim etadi. Kompaniya turli terapevtik sohalarda I dan IV fazagacha bo'lgan klinik rivojlanish jarayonini qo'llab-quvvatlovchi xizmatlar to'plamini taklif etadi. U farmatsevtika, biotexnologiya va tibbiy qurilmalar sanoati uchun klinik rivojlanish xizmatlarini; hamda rivojlanish rejasini ishlab chiqish, markaziy laboratoriyani muvofiqlashtirish, loyiha boshqaruvi, normativ-huquqiy masalalar, klinik monitoring, ma'lumotlarni boshqarish va tahlil qilish, yangi dori vositalarini ro'yxatdan o'tkazish uchun arizalarni topshirish, farmakoko'zdan xabardorlik va marketingdan keyingi klinik qo'llab-quvvatlash xizmatlarini taqdim etadi. Bundan tashqari, kompaniya bioanalitik laboratoriya xizmatlarini, klinik inson farmakologiyasini, tasvirlash xizmatlarini va klinik sinovlar uchun elektrokardiogrammani o'qish bo'yicha qo'llab-quvvatlashni taklif etadi. Medpace Holdings, Inc. 1992 yilda tashkil etilgan va Sinsinnati, Ogayo shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. August James Troendle M.D. | Chairman & CEO |
| Mr. Brandon Ebken | Chief Information Officer |
| Mr. Jesse J. Geiger BBA, CPA | President |
| Mr. John T. Wynne MBA | Senior Vice President of Commercial Operations & Clinical Pharmacology Unit |
| Mr. Kevin M. Brady | CFO & Treasurer |
| Mr. Stephen P. Ewald J.D. | Chief Compliance Officer, General Counsel & Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-23 | 10-Q | medp-20260331.htm |
| 2026-04-22 | 8-K | medp-20260421.htm |
| 2026-04-01 | DEFA14A | medpaceinc-noticecarddefa1.htm |
| 2026-04-01 | DEF 14A | medp-20260401.htm |
| 2026-03-16 | PRE 14A | medp-20260316.htm |
| 2026-02-10 | 10-K | medp-20251231.htm |
| 2026-02-09 | 8-K | medp-20260209.htm |
| 2025-10-23 | 10-Q | medp-20250930.htm |
| 2025-10-22 | 8-K | medp-20251022.htm |
| 2025-07-22 | 10-Q | medp-20250630.htm |
| Mr. Todd Meyers | Vice President of Business Development & Marketing |
| Mr. Weimin Gai MS | Senior Vice President of Biometrics |
| Ms. Lauren Morris | Associate Director of Investors Relations |
| Ms. Susan E. Burwig BSN, MA | Executive Vice President of Operations |